(19)
(11) EP 1 036 073 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.11.2006 Bulletin 2006/46

(45) Mention of the grant of the patent:
26.07.2006 Bulletin 2006/30

(21) Application number: 98966603.7

(22) Date of filing: 27.11.1998
(51) International Patent Classification (IPC): 
C07D 405/14(2006.01)
C07D 417/12(2006.01)
 C07D 405/12(2006.01)
A61K 31/495(2006.01)
(86) International application number:
PCT/EP1998/007771
(87) International publication number:
WO 1999/029687 (17.06.1999 Gazette 1999/24)

(54)

(BENZODIOXAN, BENZOFURAN OR BENZOPYRAN) DERIVATIVES HAVING FUNDIC RELAXATION PROPERTIES

(BENZODIOXAN, BENZOFURAN, ODER BENZOPYRAN) DERIVATE MIT FUNDIC ENTSPANNUNGSEIGENSCHAFTEN

DERIVES (DE BENZODIOXANE, DE BENZOFURANE OU DE BENZOPYRANE) POSSEDANT DES PROPRIETES DE RELACHEMENT FUNDIQUE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 05.12.1997 EP 97203808

(43) Date of publication of application:
20.09.2000 Bulletin 2000/38

(73) Proprietor: JANSSEN PHARMACEUTICA N.V.
2340 Beerse (BE)

(72) Inventors:
  • WIGERINCK, Piet, Tom, Bert, Paul
    B-2340 Beerse (BE)
  • VERSCHUEREN, Wim, Gaston
    B-2340 Beerse (BE)
  • SCHROVEN, Marc, Francis, Josephine
    B-2340 Beerse (BE)
  • DE BRUYN, Marcel, Frans, Leopold
    B-2340 Beerse (BE)


(56) References cited: : 
EP-A- 0 004 358
WO-A-93/17017
DE-A- 2 852 945
 EP-A- 0 048 218
WO-A-97/28157
US-A- 5 541 199
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).